Bank of New York Mellon’s Avanos Medical AVNS Stock Holding History

Bank of New York Mellon’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.69M	Buy	309,230 +4,504	+1%	+$105K	﹤0.01%	2171
2026 Q1	$4.27M	Sell	304,726 -1,351	-0.4%	-$18.2K	﹤0.01%	2406
2025 Q4	$3.44M	Sell	306,077 -7,204	-2%	-$82.4K	﹤0.01%	2529
2025 Q3	$3.62M	Sell	313,281 -41,688	-12%	-$488K	﹤0.01%	2508
2025 Q2	$4.34M	Buy	354,969 +25,472	+8%	+$320K	﹤0.01%	2354
2025 Q1	$4.72M	Buy	329,497 +13,258	+4%	+$207K	﹤0.01%	2254
2024 Q4	$5.03M	Sell	316,239 -21,550	-6%	-$426K	﹤0.01%	2293
2024 Q3	$8.12M	Sell	337,789 -44,395	-12%	-$1.01M	﹤0.01%	2042
2024 Q2	$7.61M	Sell	382,184 -9,112	-2%	-$177K	﹤0.01%	2107
2024 Q1	$7.79M	Sell	391,296 -50,643	-11%	-$979K	﹤0.01%	2096
2023 Q4	$9.91M	Sell	441,939 -11,036	-2%	-$228K	﹤0.01%	1993
2023 Q3	$9.16M	Sell	452,975 -10,184	-2%	-$231K	﹤0.01%	1997
2023 Q2	$11.8M	Buy	463,159 +1,569	+0.3%	+$41.3K	﹤0.01%	1846
2023 Q1	$13.7M	Sell	461,590 -19,690	-4%	-$572K	﹤0.01%	1751
2022 Q4	$13M	Sell	481,280 -23,966	-5%	-$586K	﹤0.01%	1785
2022 Q3	$11M	Sell	505,246 -2,385	-0.5%	-$62.3K	﹤0.01%	1858
2022 Q2	$13.9M	Sell	507,631 -46,027	-8%	-$1.32M	﹤0.01%	1747
2022 Q1	$18.5M	Sell	553,658 -1,483	-0.3%	-$47.8K	﹤0.01%	1718
2021 Q4	$19.2M	Sell	555,141 -12,355	-2%	-$399K	﹤0.01%	1740
2021 Q3	$17.7M	Buy	567,496 +17,028	+3%	+$578K	﹤0.01%	1795
2021 Q2	$20M	Sell	550,468 -6,312	-1%	-$261K	﹤0.01%	1738
2021 Q1	$24.4M	Sell	556,780 -66,906	-11%	-$3.14M	0.01%	1595
2020 Q4	$28.6M	Buy	623,686 +38,676	+7%	+$1.61M	0.01%	1410
2020 Q3	$19.4M	Buy	585,010 +20,166	+4%	+$644K	﹤0.01%	1496
2020 Q2	$16.6M	Buy	564,844 +6,870	+1%	+$199K	﹤0.01%	1556
2020 Q1	$15M	Buy	557,974 +9,590	+2%	+$286K	0.01%	1467
2019 Q4	$18.5M	Sell	548,384 -14,606	-3%	-$529K	﹤0.01%	1619
2019 Q3	$21.1M	Sell	562,990 -36,599	-6%	-$1.4M	0.01%	1504
2019 Q2	$26.1M	Sell	599,589 -44,405	-7%	-$1.9M	0.01%	1392
2019 Q1	$27.5M	Sell	643,994 -43,737	-6%	-$1.96M	0.01%	1356
2018 Q4	$30.8M	Sell	687,731 -76,628	-10%	-$4.01M	0.01%	1200
2018 Q3	$52.4M	Buy	764,359 +6,942	+0.9%	+$447K	0.01%	990
2018 Q2	$43.4M	Sell	757,417 -23,898	-3%	-$1.26M	0.01%	1099
2018 Q1	$36M	Sell	781,315 -137,483	-15%	-$6.53M	0.01%	1189
2017 Q4	$42.4M	Buy	918,798 +35,688	+4%	+$1.64M	0.01%	1106
2017 Q3	$39.8M	Sell	883,110 -2,128	-0.2%	-$90.8K	0.01%	1125
2017 Q2	$34.8M	Buy	885,238 +3,596	+0.4%	+$136K	0.01%	1204
2017 Q1	$33.6M	Buy	881,642 +80,294	+10%	+$3.13M	0.01%	1233
2016 Q4	$29.6M	Buy	801,348 +196,818	+33%	+$7.03M	0.01%	1282
2016 Q3	$21M	Buy	604,530 +18,676	+3%	+$654K	0.01%	1442
2016 Q2	$19.1M	Buy	585,854 +8,208	+1%	+$251K	0.01%	1433
2016 Q1	$16.6M	Buy	577,646 +18,293	+3%	+$487K	0.01%	1540
2015 Q4	$18.7M	Buy	559,353 +10,118	+2%	+$315K	0.01%	1435
2015 Q3	$15.6M	Sell	549,235 -56,604	-9%	-$1.97M	﹤0.01%	1591
2015 Q2	$24.5M	Buy	605,839 +89,799	+17%	+$4.03M	0.01%	1331
2015 Q1	$25.4M	Sell	516,040 -21,818	-4%	-$1.01M	0.01%	1315
2014 Q4	$24.5M	Buy	+537,858	New	+$21.1M	0.01%	1319

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SRC

Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

CIEC

Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

TMAM

Tokio Marine Asset Management Tokyo, Japan $3.23B AUM 37.2% 1-Year Est. Return

KIM

Kestrel Investment Management San Mateo, California $184M AUM 31.66% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return

Bank of New York Mellon's AVNS Position: Q2 2026 in Review

Bank of New York Mellon increased its Avanos Medical (AVNS) stake by 1.5% in Q2 2026, buying an estimated $105K and bringing the position to 309,230 shares worth $7.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2171.

Bank of New York Mellon first reported a position in AVNS in Q4 2014 and has held it in 47 quarters since. The position peaked at $52.4M in Q3 2018. 144 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Bank of New York Mellon held 309,230 shares of Avanos Medical worth $7.69M as of Q2 2026.
Bank of New York Mellon bought 4,504 Avanos Medical shares in Q2 2026, an estimated $105K.
Avanos Medical made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2171 holding.
Bank of New York Mellon first reported a position in Avanos Medical in Q4 2014 and has held it in 47 quarters since.
Bank of New York Mellon's Avanos Medical position peaked at $52.4M in Q3 2018.
144 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.